KeyGene
PrivateLast Round
Grant
Dec 2, 2024
Company Overview
KeyGene is a biotechnology company that provides research and development of breakthrough technology for crop improvement.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Computer Vision, Business Intelligence
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KeyGene Comps
Public and private peers based on sector, stage, and business model.
KeyGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 2, 2024 | ||||
| Grant | Jul 12, 2023 | ||||
| Grant | Mar 1, 2018 |
KeyGene Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2024
Received funding from Dutch government entities.
- Jul 12, 2023
Received grant funding from Netherlands Organization for Scientific Research.
KeyGene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KeyGene's valuation, stock price, and market status.
